82 related articles for article (PubMed ID: 25503115)
41. Molecular markers of tumors.
Kushlinsky NE; Gershtein ES; Ovchinnikova LK; Digaeva MA
Bull Exp Biol Med; 2009 Aug; 148(2):230-7. PubMed ID: 20027336
[TBL] [Abstract][Full Text] [Related]
42. Tumor receptor imaging.
Mankoff DA; Link JM; Linden HM; Sundararajan L; Krohn KA
J Nucl Med; 2008 Jun; 49 Suppl 2():149S-63S. PubMed ID: 18523071
[TBL] [Abstract][Full Text] [Related]
43. The molecular epidemiology of growth signal transduction proteins.
Brandt-Rauf PW; De Vivo I; Marion MJ; Hemminki K
J Occup Environ Med; 1995 Jan; 37(1):77-83. PubMed ID: 7620946
[TBL] [Abstract][Full Text] [Related]
44. Emergent Techniques for Transporter and Receptor-Based Imaging and Interventional Molecular Imaging.
Rosado-De-Castro PH; Yang D; Jeong HJ; Ogawa K; DosSantos MFH; Yeh SH
Contrast Media Mol Imaging; 2018; 2018():7615308. PubMed ID: 30670933
[No Abstract] [Full Text] [Related]
45. Farnesoid X receptor in human malignancies: an overview.
Giordano C; Barone I; Bonofiglio D; Catalano S; Andò S
J Biol Regul Homeost Agents; 2018; 32(4 Suppl. 1):1-7. 4° JOINT MEETING OF PATHOLOGY AND LABORATORY MEDICINE SIPMET–SIPMEL - SECOND JOINT MEETING IN COLLABORATION WITH ASIP–AMP–UEMS–WASPALM - 4° SIPMEL NATIONAL CONGRESS - 34° SIPMET NATIONAL CONGRESS - 4° CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE. PubMed ID: 30761858
[No Abstract] [Full Text] [Related]
46. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Costa-Silva B; Aiello NM; Ocean AJ; Singh S; Zhang H; Thakur BK; Becker A; Hoshino A; Mark MT; Molina H; Xiang J; Zhang T; Theilen TM; García-Santos G; Williams C; Ararso Y; Huang Y; Rodrigues G; Shen TL; Labori KJ; Lothe IM; Kure EH; Hernandez J; Doussot A; Ebbesen SH; Grandgenett PM; Hollingsworth MA; Jain M; Mallya K; Batra SK; Jarnagin WR; Schwartz RE; Matei I; Peinado H; Stanger BZ; Bromberg J; Lyden D
Nat Cell Biol; 2015 Jun; 17(6):816-26. PubMed ID: 25985394
[TBL] [Abstract][Full Text] [Related]
47. Organoid models of human and mouse ductal pancreatic cancer.
Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA
Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.
Zhu L; Liu Y; Chen G
Int J Clin Exp Med; 2014; 7(11):4000-7. PubMed ID: 25550908
[TBL] [Abstract][Full Text] [Related]
49. Small molecules for immunomodulation in cancer: a review.
Iyer VV
Anticancer Agents Med Chem; 2015; 15(4):433-52. PubMed ID: 25506727
[TBL] [Abstract][Full Text] [Related]
50. The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma.
Wei Y; Khalaf AT; Rui C; Abdul Kadir SY; Zainol J; Oglah Z
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189782
[TBL] [Abstract][Full Text] [Related]
51. Chrysin-Induced G Protein-Coupled Estrogen Receptor Activation Suppresses Pancreatic Cancer.
Lim HK; Kwon HJ; Lee GS; Moon JH; Jung J
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077069
[TBL] [Abstract][Full Text] [Related]
52. Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?
Garmpis N; Damaskos C; Dimitroulis D; Garmpi A; Diamantis E; Sarantis P; Georgakopoulou VE; Patsouras A; Prevezanos D; Syllaios A; Kyriakos G; Koustas E; Despotidis M; Vallilas C; Papalexis P; Antoniou EA; Kontzoglou K; Kouraklis G
In Vivo; 2022; 36(2):543-555. PubMed ID: 35241505
[TBL] [Abstract][Full Text] [Related]
53. Evolving trends in pancreatic cancer therapeutic development.
Bijou I; Wang J
Ann Pancreat Cancer; 2019 Oct; 2():. PubMed ID: 33089149
[TBL] [Abstract][Full Text] [Related]
54. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.
Qian CJ; Chen YY; Zhang X; Liu FQ; Yue TT; Ye B; Yao J
Oncol Lett; 2016 Nov; 12(5):3499-3505. PubMed ID: 27900027
[TBL] [Abstract][Full Text] [Related]
55. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.
Sparaneo A; Fabrizio FP; Muscarella LA
Oxid Med Cell Longev; 2016; 2016():7316492. PubMed ID: 27847554
[TBL] [Abstract][Full Text] [Related]
56. Nuclear receptors in pancreatic tumor cells.
Damaskos C; Garmpis N; Karatzas T; Kostakis ID; Nikolidakis L; Kostakis A; Kouraklis G
Anticancer Res; 2014 Dec; 34(12):6897-911. PubMed ID: 25503115
[TBL] [Abstract][Full Text] [Related]
57. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
59. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis.
He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X
Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513
[TBL] [Abstract][Full Text] [Related]
60. Growth factors and their receptors in pancreatic cancer.
Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
